, Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from, 2012.

, Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study. Scheres L1,2, Brekelmans M1, Ageno W3, Ay C4, Büller HR1, Eichinger S5, Hutten BA6, Klok FA7, Middeldorp S1, Schreiber K8, vol.9, pp.1581-1589, 2018.

E. Investigators, H. R. Büller, M. H. Prins, A. W. Lensin, H. Decousus et al., Oral rivaroxaban for the treatment of symptomatic pulmonary embolism, vol.366, pp.1287-97, 2012.

G. Agnelli, H. R. Buller, A. Cohen, M. Curto, A. S. Gallus et al., Oral apixaban for the treatment of acute venous thromboembolism
URL : https://hal.archives-ouvertes.fr/hal-00932477

, AMPLIFY Investigators, vol.369, pp.799-808, 2013.

L. Loffredo, F. Violi, and P. L. , Sex related differences in patients with acute venous thromboembolism treated with new oral anticoagulants. A meta-analysis of the interventional trials, Int J Cardiol, vol.212, pp.255-263, 2016.

, Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists. De Crem N1, Middeldorp S3, Verhamme P2, Peetermans M4, vol.136, pp.749-53, 2015.

, Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism. Godin R, Marcoux V1, Tagalakis V2, Vascul Pharmacol, pp.93-95, 2017.

A. Lensing, S. Middeldorp, M. Levi, J. Beyer-westendorf, B. Van-bellen et al., Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use. Martinelli I1, vol.127, pp.1417-1442, 2016.

, Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism, Bryk AH1, Piróg M2, Plens K3, Undas A4, vol.87, pp.242-247, 2016.

, Barsam S3, Patel JP3,4, Czuprynska J3, Roberts LN3, Patel RK3, Arya R3, vol.2, pp.314-319, 2016.

M. D. Apixaban-for-extended-treatment-of-venous-thromboembolism-giancarlo-agnelli, R. Harry, M. D. Buller, A. D. Ph, M. D. Cohen et al.,

M. D. Weitz, for the AMPLIFY-EXT Investigators*, N Engl J Med, vol.368, pp.699-708, 2013.

F. Huq, K. Tvarkova, A. Arafa, and R. A. Kadir, Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation, Contraception, vol.84, issue.2, pp.128-160, 2011.

, hormone replacement therapy and thrombosis Rosendaal FR1, Helmerhorst FM, Vandenbroucke JP, vol.86, pp.112-135, 2001.

, Outcome Measures for Heavy Menstrual Bleeding Stephen D Quinn and Jenny Higham Womens Health (Lond), vol.12, pp.21-26, 2016.

W. Direct-oral-anticoagulants, . Hannah-cohen, R. J. Deepa, J. Arachchillage, S. Beyer-westendorf et al., Semin Thromb Hemost, vol.42, issue.07, pp.789-797, 2016.

, Hémorragies génitales chez la femme en âge de procréer traitée pour une maladie thromboembolique veineuse : comparaison selon l'anticoagulant oral et impact sur la qualité de vie (GENB-OAC), 2017.

, Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism M. V. Huisman M. Ferreira M. Feuring M. Fraessdorf F. A. Klok, 2018.

, Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation Across BMI Categories: A Systematic Review and Meta -Analysis. Yue Zhou1 · Jianyong Ma2 · Wengen Zhu3, American Journal of Cardiovascular Drugs © Springer Nature Switzerland AG, 2019.

G. Registre, AF : les AOD font moins saigner que les AVK dans la vraie vie ! Alexandra Meilhac, 2019.

, Heavy menstrual bleeding on Rivaroxaban -Comparison with Apixaban. Myers B1,2, Webster A1, Br J Haematol, vol.176, issue.5, pp.833-835, 2017.

, The FIGO Recommendations on Terminologies and Definitions for Normal and Abnormal Uterine Bleeding, vol.29, 2011.

, Clinical Guideline 44; Heavy menstrual bleeding, 2011.

, Recommandations pour la pratique clinique Prise en charge des ménométrorragies en préménopause Élaborées par le Collège National des Gynécologues et Obstétriciens Français, 2008.

M. Lumsden, A. Gebbie, C. Holland, and . Bmj, Managing unscheduled bleeding in non-pregnant premenopausal women, vol.346, p.3251, 2013.

, How I treat heavy menstrual bleeding associated with anticoagulants. Kochawan Boonyawat1,2, Sarah H. O'Brien3,4, and Shannon M. Bates1,5. Blood First Edition Paper, 2017.

, Hémorragies génitales chez la femme en âge de procréer ayant une maladie veineuse thromboembolique et étant sous anticoagulant oral. Conduite à tenir. G. Sarlon Bartoli. La Lettre du Médecin Vasculaire n°42, 2018.

L. D. Bradley and M. D. Md;-ndeye-aicha-gueye, The medical management of abnormal uterine bleeding in reproductive-aged women, American Journal of Obstetrics & Gynecology, 2016.

A. S. Lukes, K. A. Moore, and K. N. Muse, Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial, Obstet Gynecol, vol.116, pp.865-75, 2010.

E. Berntorp, C. Follrud, and S. Lethagen, No increased risk of venous thrombosis in women taking tranexamic acid, Thromb Haemost, vol.86, issue.2, pp.714-715, 2001.

A. Sundstrom, H. Seaman, H. Kieler, and A. L. Bjog, The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database, vol.116, pp.91-97, 2009.

K. Boonyawat, A. Lensing, M. Prins, P. Prandoni, J. I. Weitz et al., Menstrual bleeding patterns in women treated with rivaroxaban: Data from the Einstein Choice trial, 2017.

A. Lensing, M. Prins, R. Bauersachs, J. Beyer-westendorf, H. Bounameaux et al., N Engl J Med, vol.376, issue.13, pp.1211-1222, 2017.

F. Klok, K. Schreiber, K. Stach, W. Ageno, S. Middeldorp et al., Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey, Thromb Res, vol.153, pp.101-107, 2017.

, DOACS in women : pros and cons, vol.181, 2019.

, UK: National Institute for Health and Clinical Excellence. NICE Guidelines, 2007.

, Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system

D. Mansour, Best Pract Res Clin Obstet Gynaecol, vol.21, issue.6, pp.1007-1028, 2007.

A. Lethaby, I. Cooke, and R. M. Cochrane, Progesterone or progesterone-releasing intrauterine systems for heavy menstrual bleeding, Database Syst Rev, p.2126, 2005.

, Dysfunctional uterine bleeding: advances in diagnosis and treatment. Munro MG, Curr Opin Obstet Gynecol, vol.13, pp.475-89, 2001.

G. A. Irvine, M. B. Campbell-brown, M. A. Lumsden, A. Heikkila, J. J. Walker et al., Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia, Br J Obstet Gynaecol, vol.105, pp.592-600, 1998.

T. Küçük and K. Ertan, Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrelreleasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers, Clin Exp Obstet Gynecol, vol.35, pp.57-60, 2008.

J. Endrikat, H. Shapiro, E. Lukkari-lax, M. Kunz, W. Schmidt et al., A Canadian, multicenter study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia, J Obstet Gynaecol Can, vol.31, pp.340-347, 2009.

M. M. Shaaban, M. S. Zakherah, S. A. El-nashar, and G. H. Sayed, Levonorgestrel-releasing intrauterine system compared to low-dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial, Contraception, vol.83, pp.48-54, 2011.

, Medical eligibility criteria for contraceptive use, 2015.

R. Hurskainen, P. Palo, E. Ekholm, S. Grenman, and A. Kivela, Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy. Inki P, vol.20, pp.381-386, 2002.

R. Faraj, E. Martindale, and S. Hill, Massive ovarian cyst haemorrhage with haemoperitoneum as a complication of long-term anticoagulation, J Obstet Gynaecol, vol.28, pp.250-251, 2008.

, Abnormal Vaginal Bleeding in Women Desiring Contraception Who Are Taking Anticoagulation Therapy, Obstet Gynecol, vol.131, issue.4, pp.632-634, 2018.

M. Goldenberg, M. Zolti, S. Hart, and D. Bider, Endometrial resectoscopic ablation in patients with menometrorrhagia as a side effect of anticoagulant therapy, Eur J Obstet Gynecol Reprod Biol, vol.77, issue.1, pp.77-79, 1998.

K. Firouznia, H. Ghanaati, A. H. Jalali, M. Shakiba, and . Iran, Uterine artery embolization for treatment of symptomatic fibroids: a review of the evidence, Crescent Med J, vol.15, issue.12, p.16699, 2013.

, Épidémiologie et physiopathologie de la dysfonction érectile, S.Droupy. Elsevier. Annales d'Urologie, vol.39, issue.2, pp.71-84, 2005.